Kimberly-Clark de Mexico SAB de CV (OTCMKTS:KCDMY – Get Free Report) posted its quarterly earnings data on Tuesday. The basic materials company reported $0.20 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.20, Zacks reports. The company had revenue of $830.35 million during the quarter, compared to analysts’ expectations of $839.55 million. Kimberly-Clark de Mexico SAB de CV had a return on equity of 164.99% and a net margin of 13.92%.
Kimberly-Clark de Mexico SAB de CV Stock Performance
OTCMKTS KCDMY traded down $0.07 during trading on Thursday, hitting $11.12. The company’s stock had a trading volume of 6,203 shares, compared to its average volume of 49,661. The company has a quick ratio of 1.36, a current ratio of 1.55 and a debt-to-equity ratio of 11.44. The firm has a 50 day moving average price of $10.98 and a 200 day moving average price of $11.44. The firm has a market cap of $6.84 billion, a P/E ratio of 15.89 and a beta of 0.67. Kimberly-Clark de Mexico SAB de CV has a 52 week low of $8.25 and a 52 week high of $12.84.
Analysts Set New Price Targets
Separately, HSBC downgraded Kimberly-Clark de Mexico SAB de CV from a “buy” rating to a “hold” rating in a research note on Wednesday, April 29th. Two analysts have rated the stock with a Hold rating, According to MarketBeat, the stock presently has a consensus rating of “Hold”.
About Kimberly-Clark de Mexico SAB de CV
Kimberly-Clark de México, SAB. de C.V. operates as one of the leading manufacturers of personal care and paper?based products in Mexico. As a locally managed subsidiary of the global Kimberly-Clark Corporation, the company focuses on the production, marketing and distribution of consumer staples designed for everyday use, ranging from facial and bathroom tissue to diapers and feminine care items.
The company’s portfolio includes well-known brands such as Kleenex and Scott for tissue products, Huggies for baby care, Kotex for feminine hygiene and Depend for adult incontinence.
Featured Stories
- Five stocks we like better than Kimberly-Clark de Mexico SAB de CV
- AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip Battle
- The 2026 Blueprint: 6 Stocks for a Brand New Portfolio
- Philip Morris Trimmed Guidance, But Its Growth Story Looks Unshaken
- Cementing the Sky: Why NVIDIA’s Bet on Nebius Matters
Receive News & Ratings for Kimberly-Clark de Mexico SAB de CV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark de Mexico SAB de CV and related companies with MarketBeat.com's FREE daily email newsletter.
